Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression
- 19 May 2009
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1796 (1), 33-40
- https://doi.org/10.1016/j.bbcan.2009.05.001
Abstract
No abstract availableThis publication has 82 references indexed in Scilit:
- Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesisNature, 2008
- Rapid Chemotherapy-Induced Acute Endothelial Progenitor Cell Mobilization: Implications for Antiangiogenic Drugs as Chemosensitizing AgentsCancer Cell, 2008
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote MetastasisCancer Cell, 2008
- Autocrine VEGF Signaling Is Required for Vascular HomeostasisCell, 2007
- A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human bloodNature Protocols, 2007
- Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytesNature Medicine, 2006
- Angiogenesis in life, disease and medicineNature, 2005
- Id family of helix-loop-helix proteins in cancerNature Reviews Cancer, 2005
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- Inflammation and cancerNature, 2002